Patents by Inventor Yannick Goumon

Yannick Goumon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of creatine kinase and derived peptides thereof to relieve pain
    Patent number: 10449235
    Abstract: Some embodiments are directed to the use of creatine kinase or fragments thereof which induce analgesia, and also to the use of pharmaceutical compositions including the same, to relieve pain.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: October 22, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE STRASBOURG
    Inventors: Yannick Goumon, Jinane Mouheiche, Alexis Laux-Biehlmann, Pierrick Poisbeau, Nisrine Kamoun
  • USE OF CREATINE KINASE AND DERIVED PEPTIDES THEREOF TO RELIEVE PAIN
    Publication number: 20180264088
    Abstract: Some embodiments are directed to the use of creatine kinase or fragments thereof which induce analgesia, and also to the use of pharmaceutical compositions including the same, to relieve pain.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 20, 2018
    Inventors: Yannick GOUMON, Jinane MOUHEICHE, Alexis LAUX-BIEHLMANN, Pierrick POISBEAU, Nisrine KAMOUN
  • USE OF CREATINE KINASE FOR PREVENTING OR TREATING ADDICTION TO OPIATES
    Publication number: 20130336953
    Abstract: The present invention relates to creatine kinase for use as a medicinal product or in the prevention or treatment of addictions or of addictive disorders associated with opiates, and to various other analytical uses or for filtration of creatine kinase.
    Type: Application
    Filed: February 3, 2012
    Publication date: December 19, 2013
    Applicants: UNIVERSITÉ DE STRABOURG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
    Inventors: Yannick Goumon, Alexis Laux - Biehlmann, Denise Stuber
  • Endogenous Morphine or a Naturally Occurring Metabolite Thereof as a Marker for Infection
    Publication number: 20100304411
    Abstract: The invention relates to a method for detecting infection in a patient comprising measuring the concentration of endogenous morphine or a naturally occurring metabolite thereof in a biological sample obtained from said patient.
    Type: Application
    Filed: December 18, 2008
    Publication date: December 2, 2010
    Applicant: JUSTUS-LIEBIG UNIVERSITAT
    Inventors: Yannick Goumon, Dominique Aunis, Marie-Helene Metz-Boutigue, Francis Schneider, Ingeborg Welters